perindopril has been researched along with Intestinal Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Fattah, MM; Arab, HH; Hassanein, EHM; Mohamed, WR; Sayed, AM | 1 |
1 other study(ies) available for perindopril and Intestinal Diseases
| Article | Year |
|---|---|
Targeting inflammation and redox aberrations by perindopril attenuates methotrexate-induced intestinal injury in rats: Role of TLR4/NF-κB and c-Fos/c-Jun pro-inflammatory pathways and PPAR-γ/SIRT1 cytoprotective signals.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Intestinal Diseases; Intestines; JNK Mitogen-Activated Protein Kinases; Male; Methotrexate; Molecular Docking Simulation; NF-kappa B; Oxidative Stress; Perindopril; PPAR gamma; Protein Binding; Proto-Oncogene Proteins c-fos; Rats, Wistar; Signal Transduction; Sirtuin 1; Toll-Like Receptor 4 | 2022 |